all 2 news articles
... patent litigation, including that relating to the generic versions of Allegra® and Neurontin®, the effects of competition on our innovative products, ...
The most common medications used to treat diabetic neuropathy are Neurontin, Lyrica and Cymbalta. The first two drugs are anti-seizure medications that ...
In the US the Food and Drug Administration is under pressure to recognise the possibility that Neurontin increases suicide risk. ...
"We forecast that Lyrica will overtake its predecessor, Neurontin, as the patient share and sales leader by 2015 -- however, even Lyrica is plagued by a ...
In May 2004, Pfizer’s subsidiary Warner-Lambert paid a $430 million fine for off-label promotion of Neurontin. The Department of Justice stated that ...
all 9 news articles